Stockreport

Aeglea -5% amid $100M equity offering [Seeking Alpha]

Aeglea BioTherapeutics, Inc.  (AGLE) 
Last aeglea biotherapeutics, inc. earnings: 8/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aegleabio.com/investor-overview
PDF Aeglea BioTherapeutics (NASDAQ:AGLE5% lowerfiled to offerShares are expected to come at $4.75-$5 each, Bloomberg reports; that's a discount of 9.9% to 14.4% from today's [Read more]